CoreWeave Q3财报后股价大涨
CoreWeave Q3财报后股价大涨
I'll start with the current quote, recent price history, and the company's news and filings.
Conclusion: the rally is a credible relief move on a strong quarter, not yet proof that fundamentals have turned. The operating story improved. Demand and backlog are real, and guidance went up. But CoreWeave is still deeply cash-consumptive and debt-funded, its customer base is concentrated, and its credit spreads were distressed days before the print. The stock is still below its 52-week high.
Data as of: the Nov 11, 2026 close (US market), , quoted at 2026-11-11 16:00 ET. Financials are from the Q3 2026 8-K (filed Nov 10, 2026) and the Q2 2026 10-Q. Credit-stress data is from CNBC reporting dated Nov 6–9, so it may have moved since.
What the stock did
- Shares rose on Nov 11, from to , on of volume. That was the best day since April 2025, per CNBC.
- The 52-week range is to . The stock is off the low.
- Market cap was about .
- CNBC reported that CoreWeave and Nebius had each lost about half their value in the month before earnings. Bonds maturing in 2031 yielded , and five-year CDS spreads were . The rebound came off a very depressed base.
Demand quality: strong on the surface, concentrated underneath
Positives
- Q3 revenue was , up year on year from $1.365B. Sequential growth was more than $1B, per management.
- Revenue backlog was at Sep 30, 2026. That is roughly ten times the 2026 revenue guidance.
- Committed contracts were of revenue in Q2 2026, per the 10-Q.
- The company reports about of customer prepayments and deposits expected in the next three months. That is a meaningful demand signal, and it also reduces funding need.
- Management says it is on capacity left for 2027. This is a CEO statement, not an audited metric, so treat it as management's view.
Concentration risk
- In Q2 2026 the top three customers were of revenue, per the 10-Q risk factors. The filing names them only as customers A, B and C.
- The 10-K for 2025, as summarized in search results, put of 2025 revenue. Concentration has fallen, but it has not gone away.
- Meta has committed up to , and OpenAI up to , per the 10-Q.
- Backlog is therefore a contract count with a few counterparties. It is not a diversified demand base.
Execution risks
- Capacity build. Active power is over and the year-end target is . That implies about 150 MW more in Q4, below Q3's pace of more than 200 MW. The target looks achievable, but it is not padded.
- Q4 revenue must ramp hard. Full-year guidance of less 9M revenue of implies Q4 revenue of to . That is to over Q3. Exit annualized run-rate revenue of requires the same ramp.
- Capex is accelerating. Full-year capex guidance is . After spent in nine months, that implies Q4 capex of to . Q3 capex was . Management says the raise reflects delivering infrastructure "sooner than planned."
- Data-center politics. Management says it sees on backlog delivery from the midterm-related shifts. Opposition to data-center projects was broad in the election, so this is a real risk the company has not disproven.
Are fundamentals supporting the rally?
Earnings quality is weak.
- Q3 GAAP operating margin was . Adjusted operating margin was . The gap is large.
- Q3 net loss was , and EPS was .
- Net interest was of revenue in Q3, at . Q4 interest is guided to .
Cash generation is deeply negative.
- Q3 operating cash flow was . Free cash flow after capex was .
- Nine-month free cash flow was .
Leverage has more than doubled this year.
- Total debt was at Sep 30, against at Dec 31, 2025. That is .
- Cash was .
- Equity was only at Sep 30.
Dilution is already happening.
- Weighted basic shares rose year on year, to 559M.
- The company raised about in convertible notes and set up an at-the-market program for up to .
Guidance is above Street expectations, which is the real driver of the rally.
- Revenue guidance midpoint is above the LSEG consensus of .
- Adjusted operating income guidance midpoint is above the Visible Alpha consensus of .
- Those figures come from the CNBC report. Adjusted operating income is a non-GAAP measure, and the company did not give a GAAP reconciliation for it.
Financing: the market's real question
- Management says the company is moving away from unsecured bonds and toward asset-level and contract-backed debt. It says a new asset-level deal, rated high investment grade, should price at . That compares with the 16%-plus yields on the 2031 bonds.
- A $2.6B DDTL facility was closed for shorter-duration customer contracts.
- Morningstar's view is that growth over five years needs more capital. With the stock down so far, equity issuance is expensive.
Bottom line
- Demand: real and large in contracted terms. Quality is limited by counterparty concentration and by the fact that backlog is not yet cash.
- Execution: on track on the Q3 data, but Q4 must deliver a steep revenue and capacity ramp while capex roughly doubles the Q3 rate.
- Fundamentals: the Q3 print improved the operating trajectory. It did not fix the balance sheet, free cash flow, or dilution. The rally is a repricing of the credit scare, supported by a beat-and-raise quarter.
What would change the view:
- Positive: Q4 revenue in the upper part of the $4.7–5.0B range, the 1.85 GW target met, and the 7–7.5% asset-level financing priced as described. Concentration falling further would also help.
- Negative: any slip in deliveries, new cuts to customer commitments, a widening of bond yields or CDS back above recent levels, or equity issuance at prices well below the recent rally.